BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3431589)

  • 1. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase.
    Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC
    NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
    Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M
    J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human liver folylpolyglutamate synthetase by non-gamma-glutamylatable antifolate analogs.
    Clarke L; Rosowsky A; Waxman DJ
    Mol Pharmacol; 1987 Jan; 31(1):122-7. PubMed ID: 3807889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
    Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
    J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate analogues. 32. Chain extension, alpha-carboxyl deletion, and gamma-carboxyl replacement by sulfonate and phosphonate: effect on enzyme binding and cell-growth inhibition.
    Rosowsky A; Forsch RA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1326-31. PubMed ID: 3385729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
    Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate analogues. 31. Meta and ortho isomers of aminopterin, compounds with a double bond in the side chain, and a novel analogue modified at the alpha-carbon: chemical and in vitro biological studies.
    Rosowsky A; Bader H; Forsch RA; Moran RG; Freisheim JH
    J Med Chem; 1988 Apr; 31(4):763-8. PubMed ID: 3351853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate analogues-27. Dual inhibition of dihydrofolate reductase and folylpolyglutamate synthetase by methotrexate and aminopterin analogues with a gamma-phosphonate group in the side chain.
    Rosowsky A; Moran RC; Forsch RA; Radike-Smith M; Colman PD; Wick MM; Freisheim JH
    Biochem Pharmacol; 1986 Oct; 35(19):3327-33. PubMed ID: 3768024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
    Rosowsky A; Forsch RA; Wright JE
    J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors.
    Mao Z; Pan J; Kalman TI
    J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential selection during therapy in vivo by edatrexate compared to methotrexate of resistant L1210 cell variants with decreased folylpolyglutamate synthetase activity.
    Rumberger BG; Schmid FA; Otter GM; Sirotnak FM
    Cancer Commun; 1990; 2(9):305-10. PubMed ID: 2206778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate.
    Tsukamoto T; Haile WH; McGuire JJ; Coward JK
    Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
    Moran RG; Colman PD; Jones TR
    Mol Pharmacol; 1989 Nov; 36(5):736-43. PubMed ID: 2586490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
    McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
    Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs.
    McGuire JJ; Piper JR; Coward JK; Galivan J
    NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
    Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
    J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of polyglutamyl derivatives of methotrexate, 10-deazaaminopterin, and dihydrofolate with dihydrofolate reductase.
    Kumar P; Kisliuk RL; Gaumont Y; Nair MG; Baugh CM; Kaufman BT
    Cancer Res; 1986 Oct; 46(10):5020-3. PubMed ID: 2428470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.